Injective drops almost 11% after renewed ecosystem support triggers selling pressure
Injective (INJ) fell 10.76%, with selling pressure intensifying after its Trench Treasury acquired 5% of the $RUNNER token supply as part of ongoing ecosystem initiatives. The down move is limited by indicators of oversold technical conditions and the presence of nearby support, even as current price action remains below short- and medium-term moving averages.
Highlights
- Injective's Trench Treasury acquired 5% of the $RUNNER token supply to advance ecosystem-focused utility projects.
- The RunUp team is using native perpetual markets and trading fees to experiment with on-chain treasury management.
- INJ/USD trades below short- and medium-term moving averages with near-term support at $6.93, resistance at $7.28, and a projected five-day range of $6.6 to $7.62.
Ecosystem expansion drives treasury moves as selling weighs on price
Injective's Trench Treasury acquired 5% of the $RUNNER token supply in a continued effort to support projects that offer utility to the Injective ecosystem. This initiative followed a previous 10% acquisition of NinjaCat's supply and is tied to supporting new value accrual mechanisms and innovative token launch strategies. The RunUp team is leveraging native perpetual markets with trading fees funding on-chain treasury strategies, and Injective’s ecosystem has surpassed 1 billion transactions and over 100 hosted projects, though price action has remained under broader selling pressure.
Short-term selling prevails as mixed signals temper oversold bounce
INJ/USD is currently trading below both its 20-day and 50-day moving averages ($8.13 and $7.53), while remaining well above the longer-term 200-day average ($5.47). This indicates short- and medium-term pressure from sellers, although the broader trend remains positive with a bullish alignment between the 50-day and 200-day averages. Immediate technical focus sits on the near-term ceiling at $7.28 and near-term floor at $6.93. Momentum indicators point to mixed signals. Moving Average Convergence Divergence (MACD) is in "Strong Buy" territory, but the Average Directional Index (ADX) remains neutral, suggesting the trend is not strongly directional. Relative Strength Index (RSI) is at 50.88 with a "Buy" forecast, while Stochastic RSI is low at 16.66, highlighting oversold conditions. Commodity Channel Index (CCI) reads neutral, and Bull/Bear Power (BBP) at 0.14 signals buyers are slightly ahead, with an oversold warning in place. The Awesome Oscillator also supports renewed buying momentum. The pair has dropped to $7.11, falling $0.86 or 10.76% since the previous close, after opening lower with a downside gap of approximately $0.63 or 7.9%. The price is positioned mid-range for the day, and intraday volatility stands at 7.50%. Overall, the tone is pressured after the open, matching some oversold momentum signals but diverging from the persistent underlying buying strength.
Earlier, analysts noted that Injective was experiencing persistent short- and medium-term weakness despite positive ecosystem developments. The current analysis reinforces these findings, with the market presenting a slightly higher probability of price consolidation between $6.6 and $7.62 in the coming days as oversold signals counter ongoing selling pressure.